The estimated Net Worth of Perry C Siatis is at least $5.64 millió dollars as of 28 February 2024. Perry Siatis owns over 9,891 units of Abbvie Inc stock worth over $2,023,152 and over the last 2 years Perry sold ABBV stock worth over $3,612,190.
Perry has made over 5 trades of the Abbvie Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Perry sold 9,891 units of ABBV stock worth $1,754,564 on 28 February 2024.
The largest trade Perry's ever made was exercising 13,753 units of Abbvie Inc stock on 23 February 2024 worth over $1,889,112. On average, Perry trades about 5,833 units every 47 days since 2023. As of 28 February 2024 Perry still owns at least 10,397 units of Abbvie Inc stock.
You can see the complete history of Perry Siatis stock trades at the bottom of the page.
Perry's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell és Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: